* Outset Medical Inc OM.OQ reported a quarterly adjusted
loss
of 90 cents per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 74
cents per share.
* Revenue rose 9.5% to $33.47 million from a year ago;
analysts
expected $31.76 million.
* Outset Medical Inc's reported EPS for the quarter was a
loss
of 90 cents.
* The mean earnings estimate of analysts had risen by
about 0.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Outset Medical Inc shares had risen by 5.1% this
quarter and
lost 25.1% so far this year.
* The company reported a quarterly loss of $43.97 million.
* Wall Street's median 12-month price target for Outset
Medical
Inc is $32.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
3 at 09:01 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.74 -0.90 Missed
Dec. 31 2022 -0.86 -0.86 Met
Sep. 30 2022 -0.81 -0.85 Missed
Jun. 30 2022 -0.70 -0.92 Missed